Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL555706 | 0.81 | L3MBTL1 (0.33) | L3MBTL1 | |
| SCHEMBL553062 | 0.81 | L3MBTL1 (0.33) | L3MBTL1 | |
| SCHEMBL554518 | 0.81 | L3MBTL1 (0.33) | L3MBTL1 | |
| SCHEMBL553105 | 0.78 | — | — | |
| SCHEMBL553106 | 0.78 | L3MBTL1 (0.32) | L3MBTL1 | |
| SCHEMBL13016456 | 0.75 | ADORA3 (0.32) | — | |
| SCHEMBL12118168 | 0.75 | L3MBTL1 (0.39) | L3MBTL1 | |
| SCHEMBL552815 | 0.75 | — | — | |
| SCHEMBL553531 | 0.75 | L3MBTL1 (0.30) | L3MBTL1 | |
| SCHEMBL552263 | 0.73 | CNR1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2371821-B1 | Volatile imidazoles and group 2 imidazole based metal precursors | AIR PROD & CHEM (US) | 2014-06-18 | — | — | EP | claimed |
| US-20120035351-A1 | Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2012-02-09 | — | — | US | claimed |
| EP-2371821-A1 | Volatile imidazoles and group 2 imidazole based metal precursors | Air Products and Chemicals, Inc. (US) | 2011-10-05 | — | — | EP | claimed |
| CN-108570657-A | container with filter | 弗萨姆材料美国有限责任公司 | 2018-09-25 | — | — | CN | disclosed |
| EP-2580223-B1 | COMPLEXES OF IMIDAZOLE LIGANDS | AIR PROD & CHEM (US) | 2017-02-08 | — | — | EP | disclosed |
| EP-2644284-B1 | Group 2 imidazolate formulations for direct liquid injection | AIR PROD & CHEM (US) | 2015-06-03 | — | — | EP | disclosed |
| US-9018387-B2 | Complexes of imidazole ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2015-04-28 | — | — | US | disclosed |
| US-8865755-B2 | Dual-acting antihypertensive agents | THERAVANCE BIOPHARMA R&D IP, LLC (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140242795-A1 | Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-08-28 | — | — | US | disclosed |
| EP-2371821-B1 | Volatile imidazoles and group 2 imidazole based metal precursors | AIR PROD & CHEM (US) | 2014-06-18 | — | — | EP | disclosed |
| US-8703103-B2 | Volatile imidazoles and group 2 imidazole based metal precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-04-22 | — | — | US | disclosed |
| US-20120214849-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2012-08-23 | — | — | US | disclosed |
| US-20120121806-A1 | Complexes Of Imidazole Ligands | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2012-05-17 | — | — | US | disclosed |
| US-20120035351-A1 | Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2012-02-09 | — | — | US | disclosed |
| US-8080572-B2 | Dual-acting antihypertensive agents | THERAVANCE, INC. (US) | 2011-12-20 | — | — | US | disclosed |
| WO-2011156699-A1 | COMPLEXES OF IMIDAZOLE LIGANDS | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2011-12-15 | — | — | WO | disclosed |
| EP-2371821-A1 | Volatile imidazoles and group 2 imidazole based metal precursors | Air Products and Chemicals, Inc. (US) | 2011-10-05 | — | — | EP | disclosed |
| US-20110230525-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | THERAVANCE, INC. (US) | 2011-09-22 | — | — | US | disclosed |
| US-7863309-B2 | imidazole or triazole derivatives such as 4-[4-((R)-1-Benzyl-2-hydroxycarbamoylethylcarbamoyl)-2-butylimidazol-1-ylmethyl]benzoic acid methyl ester, used for treating congestive heart failure or as hypotensive agents | THERAVANCE, INC. (US) | 2011-01-04 | — | — | US | disclosed |
| US-20100022599-A1 | imidazole or triazole derivatives such as 4-[4-((R)-1-Benzyl-2-hydroxycarbamoylethylcarbamoyl)-2-butylimidazol-1-ylmethyl]benzoic acid methyl ester, used for treating congestive heart failure or as hypotensive agents | THERAVANCE BIOPHARMA R&D IP, LLC | 2010-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110230525-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | AGTR1, REN, AGTR2 | L3MBTL1 4295/4885 |
| US-20120035351-A1 | Volatile Imidazoles and Group 2 Imidazole Based Metal Precursors | CACNG5, BST2, API5 | L3MBTL1 2582/4885 |
| US-20120121806-A1 | Complexes Of Imidazole Ligands | ICOSLG, CLTC, PICALM | L3MBTL1 2147/4885 |
| US-20100022599-A1 | imidazole or triazole derivatives such as 4-[4-((R)-1-Benzyl-2-hydroxycarbamoylethylcarbamoyl)-2-butylimidazol-1-ylmethyl]benzoic acid methyl ester, used for treating congestive heart failure or as hypotensive agents | AGTR1, REN, AGTR2 | L3MBTL1 1229/4885 |
| US-20120214849-A1 | DUAL-ACTING ANTIHYPERTENSIVE AGENTS | AGTR1, REN, AGTR2 | L3MBTL1 4295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.